Lobucavir (original) (raw)

About DBpedia

Lobucavir (previously known as BMS-180194, Cyclobut-G) is an antiviral drug that shows broad-spectrum activity against herpesviruses, hepatitis B and other hepadnaviruses, HIV/AIDS and cytomegalovirus. It initially demonstrated positive results in human clinical trials against hepatitis B with minimal adverse effects but was discontinued from further development following the discovery of increased risk of cancer associated with long-term use in mice. Although this carcinogenic risk is present in other antiviral drugs, such as zidovudine and ganciclovir that have been approved for clinical use, development was halted by Bristol-Myers Squibb, its manufacturer.

thumbnail

Property Value
dbo:abstract Lobucavir (previously known as BMS-180194, Cyclobut-G) is an antiviral drug that shows broad-spectrum activity against herpesviruses, hepatitis B and other hepadnaviruses, HIV/AIDS and cytomegalovirus. It initially demonstrated positive results in human clinical trials against hepatitis B with minimal adverse effects but was discontinued from further development following the discovery of increased risk of cancer associated with long-term use in mice. Although this carcinogenic risk is present in other antiviral drugs, such as zidovudine and ganciclovir that have been approved for clinical use, development was halted by Bristol-Myers Squibb, its manufacturer. (en)
dbo:alternativeName Lobucavir (en)
dbo:casNumber 127759-89-1
dbo:chEMBL 23550
dbo:drugbank DB12531
dbo:fdaUniiCode 8U5PYQ1R2E
dbo:kegg D04757
dbo:pubchem 135413519
dbo:thumbnail wiki-commons:Special:FilePath/Lobucavir_structure.png?width=300
dbo:wikiPageID 63120463 (xsd:integer)
dbo:wikiPageLength 7310 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID 991292230 (xsd:integer)
dbo:wikiPageWikiLink dbr:Primer_(molecular_biology) dbr:Nucleotide dbr:Antiviral_drug dbr:Cytomegalovirus dbr:DNA_polymerase dbr:DNA_replication dbc:Antiviral_drugs dbc:Diols dbc:Purines dbr:Ganciclovir dbr:Zidovudine dbr:Bristol-Myers_Squibb dbr:Carcinogenesis dbr:Reverse_transcriptase dbc:Cyclobutanes dbr:Guanine dbr:HIV/AIDS dbr:Hepatitis_B dbr:Herpes_simplex_virus dbr:Human_betaherpesvirus_5 dbr:Herpesvirus dbr:Hepadnavirus
dbp:c 11 (xsd:integer)
dbp:casNumber 127759 (xsd:integer)
dbp:chembl 23550 (xsd:integer)
dbp:chemspiderid 54782 (xsd:integer)
dbp:drugbank DB12531 (en)
dbp:h 15 (xsd:integer)
dbp:iupacName 2 (xsd:integer)
dbp:kegg D04757 (en)
dbp:legalUs Investigational New Drug (en)
dbp:molecularWeight 265.270000 (xsd:double)
dbp:n 5 (xsd:integer)
dbp:o 3 (xsd:integer)
dbp:pubchem 135413519 (xsd:integer)
dbp:smiles C1[C@@H]CO (en)
dbp:stdinchi 1 (xsd:integer)
dbp:stdinchikey GWFOVSGRNGAGDL-FSDSQADBSA-N (en)
dbp:tradename Lobucavir (en)
dbp:unii 8 (xsd:integer)
dbp:wikiPageUsesTemplate dbt:Antivirals dbt:Drugbox dbt:Reflist dbt:Antiinfective-drug-stub
dcterms:subject dbc:Antiviral_drugs dbc:Diols dbc:Purines dbc:Cyclobutanes
rdf:type owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:Drug
rdfs:comment Lobucavir (previously known as BMS-180194, Cyclobut-G) is an antiviral drug that shows broad-spectrum activity against herpesviruses, hepatitis B and other hepadnaviruses, HIV/AIDS and cytomegalovirus. It initially demonstrated positive results in human clinical trials against hepatitis B with minimal adverse effects but was discontinued from further development following the discovery of increased risk of cancer associated with long-term use in mice. Although this carcinogenic risk is present in other antiviral drugs, such as zidovudine and ganciclovir that have been approved for clinical use, development was halted by Bristol-Myers Squibb, its manufacturer. (en)
rdfs:label Lobucavir (en)
owl:sameAs wikidata:Lobucavir dbpedia-fa:Lobucavir https://global.dbpedia.org/id/2YGzt
prov:wasDerivedFrom wikipedia-en:Lobucavir?oldid=991292230&ns=0
foaf:depiction wiki-commons:Special:FilePath/Lobucavir_structure.png
foaf:isPrimaryTopicOf wikipedia-en:Lobucavir
is dbo:wikiPageWikiLink of dbr:List_of_drugs:_Lo
is foaf:primaryTopic of wikipedia-en:Lobucavir